Why Capsule Failed: Unit Economics | Startup Autopsy
$300M
Raised
7y
Time to collapse
// startup autopsy
Capsule
NYC pharmacy delivery startup raised $300M from L Catterton—then shut down operations in March 2023 after failing to expand its tech-first pharmacy model beyond its home city.
Evaluating only Capsule’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. That’s exactly how it died.
Key Events Timeline
FOUNDING
Capsule founded
DOWN ROUND
Down round or bridge financing
SHUTDOWN
Silent Shutdown: Capsule ceases operations
Full Analysis
Free · no account needed
Documented cause
Capsule was founded in New York in 2016 to reinvent the pharmacy experience: free same-day delivery, proactive refill management, pharmacist messaging, and a modern app interface. The company raised $300M from Glade Brook Capital, L Catterton, and others. The model required maintaining licensed pharmacies, pharmacist staff, and delivery infrastructure in each city—a capital-intensive local business that did not benefit from software-style economies of scale. Expansion from New York to other cities proved expensive and slow. The company also faced competition from Amazon Pharmacy, CVS same-day delivery, and the growing mail pharmacy sector. Capsule shut down operations without warning in March 2023.
Lesson
“Pharmacy delivery expansion economics must be modelled per state, not per country. Calculate the full cost to reach pharmacy profitability in state 2 (licences, staff, PBM contracts, delivery network) and ask: if this costs $30M per state and there are 50 states, does the total capital required exceed what the market will provide?”